Characterization of morphine-induced hyperalgesia in male and female rats

Joseph R Holtman1, Elzbieta P Wala

  • 1Department of Anesthesiology, College of Medicine, University of Kentucky, Lexington, KY 40536-0293, USA. jrjr@uky.edu

Pain
|March 1, 2005
PubMed

Insights

Low-dose morphine can paradoxically increase pain sensitivity (hyperalgesia) in a dose- and sex-dependent manner. Tolerance to this effect can develop, altering morphine

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • Morphine, a widely used opioid analgesic, can exhibit complex dose-dependent effects on pain perception.
  • Understanding the mechanisms underlying morphine's hyperalgesic effects is crucial for optimizing pain management strategies.

Purpose of the Study:

  • To characterize the pain-enhancing (hyperalgesic) effects of morphine.
  • To investigate the influence of dose, sex, and administration mode on morphine-induced hyperalgesia.
  • To explore the role of N-methyl-d-aspartate (NMDA) receptors and the development of tolerance.

Main Methods:

  • Utilized thermal and mechanical pain stimuli in a rat model.
  • Administered varying doses of morphine via acute and chronic routes.
  • Investigated the effects of the NMDA receptor antagonist ketamine.
  • Assessed changes in pain sensitivity and analgesic efficacy following chronic morphine administration.

Main Results:

  • Low-dose morphine (subanalgesic) induced hyperalgesia in a dose- and sex-related manner, being more pronounced in female rats.
  • Morphine-induced hyperalgesia was inversely related to dose and antagonized by ketamine.
  • Tolerance to morphine hyperalgesia developed with chronic low-dose administration.
  • In tolerant rats, morphine analgesic efficacy increased in females, sex differences in analgesia were attenuated, and tolerance to analgesic effects was delayed.

Conclusions:

  • Morphine can exert paradoxical pain-enhancing effects, particularly at low doses, with significant sex-based differences.
  • NMDA receptor antagonism and tolerance development modulate these hyperalgesic and analgesic effects.
  • Findings suggest clinical implications for optimizing mu-opioid therapy and managing potential hyperalgesia.